Japanese Guideline for Occupational Allergic Diseases 2014  by Dobashi, Kunio et al.
Allergology International Vol 63, No3, 2014 www.jsaweb.jp 421
Japanese Guideline for Occupational
Allergic Diseases 2014
Kunio Dobashi1, Kazuo Akiyama2, Atsushi Usami3, Hiroo Yokozeki4, Zenro Ikezawa5,
Naomi Tsurikisawa6, Yoichi Nakamura7, Kazuhiro Sato8, Jiro Okumura9, on behalf of
Committee for Japanese Guideline for Diagnosis and Management of Occupational Allergic
Diseases10 and Japanese Society of Allergology
ABSTRACT
In 2013, a guideline for occupational allergic diseases was published for the first time in Japan. Occupational
allergic diseases are likely to worsen or become intractable as a result of continuous exposure to high concen-
trations of causative antigens, and are socioeconomically important diseases with which the patients might
sometimes lose jobs due to work interruptions. Guidelines for occupational allergic diseases have been pub-
lished in many countries. This guideline consists of six chapters about occupational asthma, occupational aller-
gic rhinitis, occupational skin diseases, hypersensitivity pneumonitis and occupational anaphylaxis shock, and
legal aspects of these diseases. The guideline is characterized with the following basic structure: Clinical Ques-
tions (CQs) are set with reference to Minds (Medical Information Network Distribution Service), statements by
the committee are correspondingly listed, recommended grades and evidence levels are defined, and then de-
scriptions and references are indicated.
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1. Significance and Characteristics
A large number of case reports have been accumu-
lated on occupational allergic diseases. In some
cases, such as asthma caused by amorphophallus
konjac or ascidian, improvement of working environ-
ment based on evidence from epidemiologic studies
and analyses of antigens resulted in reduction in
asthma cases at the workplace. However, because of
the occupational features of the diseases, only case
reports have been presented in many cases. Although
guidelines for individual allergic diseases have been
published by allergologic associations, the descrip-
tions of occupational factors are generally minimal. In
fact, guideline for diagnosis and management of occu-
pational allergic diseases has not been developed.
If a worker with an occupational allergic disease
doesn’t consider it an occupational disease, or if an af-
fected workers bear it and take no measures or treat-
ment, extensive exposure at the workplace will per-
sist, causing the disease to worsen or become intrac-
table. Depending on the circumstances, patients
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Fig.　1　Work-related asthmas and their classifi cations. From reference 1.
Work-aggravated (exacerbated) asthmaOccupational asthma, OA
Sensitizer-induced asthma
Work-related asthma, WRA
Irritant-induced asthma
Including reactive airway 
dysfunction syndrome (RADS)
Table　1　Recommended grades
Grades Meaning
A Strongly recommended to apply
B Recommended to apply
C1 Should apply
C2 Should not apply
D Recommended not to apply
might lose their job and therefore face economic diffi-
culties. Therefore, it is extremely important to iden-
tify occupational allergic disease cases in their early
stages and take appropriate preventive measures for
the social lives of patients. In Europe and the USA,
several guidelines for occupational allergic diseases
have been published. It is extremely significant that
the guideline for diagnosis and management of occu-
pational allergic diseases have been published for the
first time in Japan.1
This guideline is designed to assist healthcare pro-
fessionals engaging in ordinary diagnosis and man-
agement of allergic diseases to practice early detec-
tion and treatment and early prevention in patients
with allergic diseases induced and worsened by occu-
pational factors. We hope that this guideline will be
used for ordinary diagnosis and management of occu-
pational allergic diseases and help the patients.
The guideline has a basic structure in which Clini-
cal Questions (CQ) are set with reference to Minds
(Medical Information Network Distribution Service),
statements by the committee are listed, recommenda-
tion grades and evidence levels are defined, descrip-
tions and references are indicated. Also, legal aspects
are written in full.
As for occupational allergic diseases, because new
substances have been continually produced due to
technical innovation, and working environments have
been changing due to changes in industrial struc-
tures, new occupational asthmas can always arise. In
the future, we will continue to revise the guideline
every three years, in order to maintain a high level of
evidence for the guideline.
In this paper, recommended grades are written in
parentheses following each statement, as shown in
Table 1.
2. Occupational Asthmas
2.1. Definitions and Classifications
CQ1: What are the definitions and classifications of
occupational asthmas? (Fig. 1)
Asthmas related to occupations are called “work-
related asthmas (WRAs).” These can be classified
into “occupational asthmas (OAs)” and “work-
aggravated (exacerbated) asthmas.” OAs are those
related to occupations and caused by antigens exist-
ing in the workplace. OAs can be further divided into
“sensitizer-induced asthmas,” which are associated
with an immunological and allergic mechanism, and
“irritant-induced asthmas,” which occur due to aspira-
tion of a large quantity of an irritant at the workplace.
Work-aggravated (exacerbated) asthmas are those
preexisted and aggravated by gas, cool air, or dust as-
pirated at the workplace.2 In Japan, work-aggravated
(exacerbated) asthmas are generally not included in
OAs. [Minds Grade A]
2.2. Prevalence
CQ2: What is the proportion of population-attributable
risk of occupational factors in adult asthmas?
The proportion of population-attributable risk of occu-
pational factors in adult asthmas is approximately
15%.3
CQ3: How does the prevalence by occupation group in
cross-sectional studies?
High prevalence rates are found in painters (isocy-
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Table　2　Incidence of occupational asthmas in main occupational groups according to cross-sectional studies
Occupation/exposed antigen Number of cases Incidence (%) Country
Snow crab processors 303 15.6 Canada
Guar gum (natural polysaccharide) 151  3.0 Canada
Painters (isocyanate) 730  7.1
(All subjects were non-smokers.)
Italy
Poultry workers 134 11.0 South Africa
Rats allergens 113  4.4 France
Natural rubber latex 
(health care workers in general hospital)
196  7.1 Italy
Florists 128 14.1 USA
Supermarket bakery workers  66  9.0 UK
Strawberry growing industry workers  43  4.7 Japan
Oyster shucker (Sea squirt) 250-417 18.0-36.0 Japan
Adapted from reference 4.
Table　3　Classifi cation of evidence levels
Panel Consensus
Evidence levels
Overseas Japan
Epidemiologic studies and analyses 
of antigens have been published.
(1) (1)
Multiple case reports have been 
presented.
(2) (2)
One case is reported. (3) (3)
anate); bread and needle makers; nurses; those who
work with chemicals; animal handlers; welders; those
working in food-processing, and lumbering; and so
forth (Table 2).
2.3. Antigens
CQ4:What are causative antigens?
Causative antigens are divided into antigens of high
molecular weight, such as those derived from ani-
mals and plants, and antigens of low molecular
weight, such as chemicals and metals. [A]
CQ5: What is the standard for a causative antigen des-
ignation?
For antigens reported in Japan, the evidence levels
are defined as shown in Table 3 and are written as in-
dividual causative substances (Table 4). As for epide-
miologic studies, cases that the prevalence in specific
occupational group is reported were made “Present.”
CQ6: What types of antigens in conventional OAs were
most common?
Substances derived from animals or plants. [C1]
CQ7:What antigens have increased recently?
Minerals and low molecular weight substances.2,4
[C1]
CQ8: What are the problems in OAs caused by chemi-
cals?
Because the specific immunoglobulin E (IgE) anti-
body cannot be easily detected, diagnosis is difficult.5
[A]
CQ9:What is the influence of genetics?
The disease occurs as a result of some interaction be-
tween multiple genetic factors and environmental fac-
tors. It can be expected that understanding molecular
pathologic conditions of OAs will advance by identify-
ing genetic factors and that preventive measures
such as setting environmental exposure limits accord-
ing to individual onset risks will be practiced. [C1]
CQ10:What are risk factors?
Heredity, exposure to high concentrations of causa-
tive substances with high frequency, atopic diathesis,
and smoking. [C1]
2.4. Diagnosis
CQ11:What is the most important factor in diagnosis?
(1) Suspecting an OA. Questioning the patient is
most important. [A]
(2) In diagnosis of sensitizer-induced asthma, the di-
agnosis rate increases with the combination of multi-
ple examinations as well as medical history.6 [A]
(3) Diagnosing it as early as possible.7 [A]
CQ12: Are questionnaires useful for definitive diagno-
ses?
Although useful, the specificity of questionnaires is
low.8 [A]
CQ13: Is peak flow useful for definitive diagnosis?
It is useful. The daily continuous peak flow measure-
ment has a high sensitivity and specificity in the diag-
nosis of OA, and is thus the most useful method.9 [A]
CQ14: Is the non-specific airway hypersensitivity test
useful for diagnosis?
(1) Airway hypersensitivity changes associated with
occupations are helpful for diagnosis. [B]
(2) It is desirable that, in the same patient, the stan-
dard method test is conducted at the same facility.
[B]
CQ15: Is the antigen inhalation challenge test necessary
for definitive diagnosis?
Dobashi K et al.
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Table　4　Aspirated substances and occupations assumed to induce occupational asthma
Aspirated substances inducing 
occupational asthmas Occupation or other
Evidence levels
Overseas Japan
A. Plant-derived
I. Powder dust
1. Grain dust
Konjac fl our Makers of konjac (3) (1)
Buckwheat fl our Soba noodle business
Soba noodle makers and distributors
(1) (1)
Wheat fl our Baking industry, Noodle makers, rice millers (1) (1)
Barley fl our Workers for milling factories (1) (1)
Animal feed dust Animal feed business (3)
Rice Families of rice millers (2) (3)
Rice bran Rice millers (2)
Rice straw Rice farmers, tatami mat makers (1) (3)
2. Wood dust
Red cedar Red cedar wood industry (1) (1)
Clethra Woodworkers (2)
Zelkova Woodworkers (1)
Mulberry tree Furniture makers (3)
Magnolia Wood industry (3)
White birch Disposable chopsticks makers (1) (3)
Lauan Wood industry (1)
Chinese quince Furniture makers (1)
Rosewood Furniture makers (1)
Paulownia Lumber/wood industry (1)
Japanese oak Oak lumber producers (3)
Yellow pine/other pines Carpenters (1) (2)
Box Furnishing producers (3)
Japanese cedars Wood processors (1) (3)
Ayous Carpenters (2) (3)
White ash Furniture workers/carpenters (2) (3)
Sengon laut Furniture workers/carpenters (3)
3. Other powder dust
Unseasoned Japanese angelica tree sap dust Taranome producers (3)
Cotton dust Drop curtain/fl ag makers (1) (2)
Coffee bean dust Traders handling these beans (1) (1)
Chinese sesame non-oil ingredients Quality inspection workers (1) (3)
Powder dust of sunfl ower seeds, Lenovatole 
(cosmetics containing sunfl ower seeds)
Confectioners handling sunfl ower seeds, beauticians 
using lenovate essence containing sunfl ower seeds
(3) (3)
Shoot of tea, downy hair of new leaves Tea-picking workers (2)
Tea packing business (overseas) 
Green tea components (Japan)
Tea makers (1) (1)
Downy hair and pollen of mum Mum planters in plastic greenhouses (3)
Components of statice fl owers Statice planters (3) (3)
Tomato stems Planters in plastic greenhouses (1)
Lettuce leaves Planters in plastic greenhouses (1) (2)
Stems and pollen of Japanese butterbur Intake of Japanese butterbur (3)
Mellon crusty trichome Planters in plastic greenhouses (2) (2)
Pepper Food processors (1) (3)
Indian rice fl our Kamakura-bori workers (Indian rice users) (3)
Smoke of tabaco Resort hotel workers (3)
(Continued)
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Aspirated substances inducing 
occupational asthmas Occupation or other
Evidence levels
Overseas Japan
II. Pollens and spores
1. Occupational pollinosis
Sugar beet pollen Staff in sugar beet research institutes (1) (3)
Rose pollen Staffs in rose research institutes (3)
Hogweed pollen Hogweed pollen researchers (1) (1)
Cocksfoot pollen Commercial growers of cocksfoot for cow feed (1) (1)
Italian ryegrass pollen Cattle breeders (2) (2)
Strawberry pollen Strawberry growers in plastic greenhouses (1) (2)
Peach pollen Flower pickers at peach fi elds (1) (2)
Pear pollen Pear growers (fl ower picking, anther release, artifi cial 
mating)
(1)
Apple pollen Hand pollinators (1) (1)
Cosmea pollen Florists handling cosmeas (3)
Mum pollen Mum growers with electric illumination in plastic 
greenhouses, Buddhist monks frequently handling 
mums at temples
(2) (2)
Insect fl ower pollen Insect fl ower growers on the Setonaikai coast (2)
Grape pollen Workers growing grapes in plastic greenhouses and 
shaking shelves to spread the pollen
(2)
Umbrella pine pollen Distributors of umbrella pine for gifts at Koyasan (3)
Green pepper pollen Green pepper quick growers in plastic greenhouses (1) (3)
Cedar pollen Workers of electric companies who conduct inspec-
tions and look around of transformer stations located 
at cedar forests
(1)
Corn pollen Dairy farmers who raise corn as feed (1) (3)
Cape marigold pollen Cape marigold growers in plastic greenhouses (3)
Gloriosa pollen Gloriosa growers in plastic greenhouses (3) (3)
China grass pollen Sellers of diagnostic products for the China grass pol-
linosis
(1)
Fennel, blue lace, lace fl ower Flower arrangement specialists using umbelliferae (3)
Rice pollen Personnel at rice cropping test organizations (1) (2)
Tomato pollen Tomato growers in plastic greenhouses (3) (2)
Strelitzia reginae pollen Strelitzia reginae growers for ornamental use in plas-
tic greenhouses
(3)
2. Spores
Shiitake mushroom spore Shiitake mushroom growers in plastic greenhouses (1) (1)
Club moss spore Dental technicians using lycopodium for making artifi -
cial teeth
Policemen using lycopodium for collecting fi nger-
prints
(2) (3)
Wheat smut fungus spore Farmers growing wheat (crop season) (3)
3. Fungus
Trichophyton (fungus) Judo bonesetter coming into contact with tinea pa-
tients
(1) (3)
B. Animal-derived
1. Arthropod, insects
Sericultural industry
Mature silkworm urine Sericulturists using mabushi (1)
Scary hair of moth of silkworm Sericulturists (1)
Carp food Carp growers (2)
Dried pupas Silk handlers (1) (1)
Bee poison Silk sericin (1) (3)
Table　4　(Continued)
(Continued)
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Aspirated substances inducing 
occupational asthmas Occupation or other
Evidence levels
Overseas Japan
Trichopteran powder dust Fishing gear business capturing Trichopteran as 
fi shing food
(1) (1)
House dust mite antigen Researchers working toward the separation and 
purifi cation of house dust mite antigens
(1) (1)
Tetranychidae, mandarin orange spider mite Workers cultivating yuzu (1) (1)
Pupas of arrowhead Coccoidea Workers who clip mandarin orange trees (3)
2. Fish
Ricinus lees, fi sh lees powder dust Farmers using mixed feed (3)
Shrimp powder dust Dried shrimp makers (1) (3)
Sardine powder dust Dried sardine makers (1) (3)
3. Birds
Chicken farming
Chick feathers Chick hatching stations (2)
Poultry manure and chicken feathers Poultry dealers (2) (3)
4. Mammals
Human dander Persons in charge of cosmetic at the cosmetic 
companies, hairdressers
(1) (3)
Pig stool powder dust Pig industry (2) (3)
Dog skin Managers of animal hospitals (3)
Cat skin Managers of animal hospitals (3)
Cow hair Cattle farmers (2) (3)
Cow hair/furfur Horse-riders, family of people who work in stables (1) (3)
Animal hair Hair pencil makers (2)
Japanese deer hair Persons handling deer hair (3) (2)
Sheep wool Persons handling sheep wool (3) (3)
Furfur of guinea pig and rabbit, 
body components of frogs
Personnel raising animals in university laboratories, 
researchers who experiment on frogs
(1) (1)
5. Other
Body components of ascidian Oyster shuckers (1)
Soft coral denronephthytia nipponica Crawfi sh fi shermen (1)
Shell powder dust Shell polishers (1) (3)
Pearl powder dust Workers who form necklace holes at peal processing 
factories
(2)
C. Drugs and food
1. Drug powder dust
Diastase, Gentian, Thyradin Pharmacists (1)
Pancreatin Pharmacists (3)
Matromycin, Sigmamycin Pharmaceutical company employees (3)
Penicillin Person in charge of experiments at the pharmaceutical 
company
(2) (3)
Kallikrein Pharmaceutical factory employees (2)
Gastropylore Pharmacists (3)
INAH Pharmacists preparing isoniazid (3) (3)
Trapidil, Ticlopidine Pharmacists (3)
Cetraxate hydrochloride pantothenic acid Pharmaceutical factory employees (2)
2. Foods
Stevia powder Traders adding stevia to sucrose (3)
Galacto-oligosaccharide Traders of oysters removed from their shells (1)
Glycyrrhiza powder dust Workers extracting pigment from glycyrrhiza (3) (3)
Table　4　(Continued)
(Continued)
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Aspirated substances inducing 
occupational asthmas Occupation or other
Evidence levels
Overseas Japan
Dokusogan ingredients such as glycyrrhiza 
and smilax glabra
Person in charge of manufacturing at the pharmaceu-
tical company
(3)
Honey Families of apiary workers (1) (3)
Royal jerry Traders dividing royal jerry into sacks (3)
Bacilus subtilis (enzyme-containing cleanser) Cleaning business using enzyme-containing cleansers (1) (1)
Oxygen products containing amylase as a 
main component (diastatic enzyme products 
for making alcohol)
Sake brewers (3)
Milk-curdling enzyme Rennin 
(for making cheeses)
Cheese plant employees (1) (3)
Lysozyme, glycine, glucono delta lactone Food preservative manufacturers (3) (2)
Food additive powder dust (Pearl Meat F, FR 
powder) (Main component: egg white)
Employees handling food additives at meat processing 
factories
(3) (2)
D. Metals and chemicals
1. Chemicals
Dyestuffs
Dyestuff intermediates, Chicago Red, 
Pyrazolone derivatives
Employees of dye-stuff factories (3) (3)
Reactive dyestuffs, Reactive Orange 7 Employees of dye-stuff factories (3)
Arabian rubber powder dust Printing factory workers (2) (3)
Isocyanate
Toluene diisocyanate (TDI), Methylene 
bisphenyl isocyanate (MDI), Hexameth-
ylene diisocyanate (HDI)
Polyurethane resin factory workers, Students making 
fi gurative objects with urethane resin, Orthopedists 
fi xing plaster casts, House painters using coating 
reinforcement agents
(1) (1)
Cyanoacrylate adhesives (Aron Alpha®), 
Cyanon
Makers of ear pieces for acoustic aid, plate makers (2) (2)
Anhydrous pyromellitic acid Traders handling anhydrous pyromellitic acid as a 
raw material for heat-resistant resin synthetics
(1) (3)
Stimulation of anti-rust oil Welders aspirating smoke of anti-rust oil at the time 
of welding
(2) (3)
2. Metals
Chrome
Chrome in cement Cement factory workers (3) (1)
Bichromate of soda, etc. Metal factory workers, coating factory workers (1) (3)
Chloroplatinic acid Makers of platinum oxygen sensors 
(automobile internal combustion)
(1) (1)
Tungsten, etc. Workers at factories making cemented carbide tools (1)
Cobalt Workers at factories making cemented carbide tools (1) (3)
Adapted from reference 1.
Table　4　(Continued)
(1) It is the gold standard for diagnosing sensitizer-
induced asthma, and is thus useful for identifying
new antigens. [C1]
(2) Because it is risky, regardless of whether the anti-
gen is new or known, it is not essential when diagno-
ses can be made with other methods. [C1]
CQ16: Are immunological examinations useful?
(1) They are useful for identifying high molecular
weight antigens in sensitizer-induced asthma. [A]
(2) They are not useful for identifying low molecular
weight antigens. [C2]
2.5. Treatment and Management
CQ17: Are management methods by classification use-
ful?
This question is outlined in Table 5.2,4,7 [B]
CQ18: Is avoidance of causative antigens effective?
Yes, it is effective. [B]
CQ19: How does the drug treatment proceed?
Treatment of asthma is conducted according to the
guideline for diagnoses and management.10 [B]
CQ20: Can one continue working if a drug treatment is
conducted?
(1) It is not recommended to conduct the drug treat-
ment alone without changing the working environ-
Dobashi K et al.
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Table　5　Dealing policies for occupational asthmas
Dealing policies for occupational asthmas Dealing policies for work-aggravated (exacerbated) asthmas
1. Sensitizers
Avoidance of exposure to sensitizers
Depending on situation, reducing exposure and antigen-specifi c 
immune-therapy are taken into consideration.
Exposed workers are inspected.
2. Irritants
Reduction of exposure to irritants
3. Sensitizers and irritants
Appropriate treatment of asthma
Follow-up of patients; Career change to prevent worsening asthma
Aid for economic compensation for patients
Consideration of preventing onset in other workers
1. Appropriate treatment of asthma
2. Reduction of asthma-exacerbating factors inside
and outside workplace
3. Follow-up of patients; Career change to prevent 
worsening asthma
4. Consideration of economic compensation
5. Consideration of preventing onset in other workers
From reference 1.
ment. [A]
(2) For irritant-induced asthma or work-aggravated
asthma, another consideration is that when asthma
control is done through drug treatment, the same
work might be continued with reduced exposure to
the causative agent. [C1]
CQ21: Is antigen-specific immunotherapy effective?
When subjects have sensitizer-induced asthma, it is
effective for some causative agents. [B]
CQ22: To confirm regarding symptoms or improvement
in respiratory function after avoidance of exposure to an
antigen, how long a follow-up period is necessary?
Several years are necessary after avoidance of the
causative agent.11 [A]
CQ23:What are conditions that facilitate symptom alle-
viation and enhance respiratory function after avoiding
exposure to antigens?
Those conditions include the respiratory function at
the time of diagnosis, exposure period to a causative
agent, and age at time of diagnosis.12 [A]
2.6. Prevention
CQ24: What is the highest priority in the management
and prevention of hazardous working environments?
Complete avoidance of inhaled antigens at the early
stage is paramount. This can be achieved by chang-
ing to less sensitizing alternative agents or com-
pletely sealing off relevant areas.2,4,13 [A]
CQ25: Is it useful to reduce exposure to antigens by set-
ting up ventilation devices at the workplace?
Although it is effective, complete avoidance is more
effective. [B]
CQ26: Is it effective to substitute materials with lower
antigenicity or without antigenicity?
If materials with no or lower antigenicity can be used,
it will be as effective as either a reduction or complete
avoidance of exposure to antigens. [A]
CQ27: Is it effective to wear a gas protection mask, dust
protective masks, protective clothing, and so forth at the
workplace?
It is effective for avoiding and reducing exposure to
antigens. [B]
CQ28: Is it effective to inspect for the presence or ab-
sence of atopy before employees begin working?
This might not always be effective.12 [C1]
CQ29: Is education on occupational health effective as
a preventative measure?
It is effective to educate about the symptoms of OA,
exacerbation factors, protective tools, treatment, and
so forth. [B]
CQ30: Is it effective for industrial physicians to conduct
an inspection tour through workplaces once or more per
month?
It is effective that industrial physicians conduct a tour
inspection through workplaces, evaluate manage-
ment of working environment at workplaces and
management of works, and advise and recommend
business owners at a health and safety committee
meeting. [C1]
3. Occupational Allergic Rhinitis
3.1. Definition
CQ1: What is the definition of occupational allergic
rhinitis?
(1) Occupational allergic rhinitis is defined as allergic
rhinitis induced, caused and worsened by inhaling
work-derived agents into the nasal cavity.14
(2) Antigens are not limited to workplace-specific
substances.
(3) Allergic rhinitis is an allergic disease with three
main symptoms―sneezing, watery rhinorrhea, and
nasal stuffiness―which are mediated by IgE.
(4) In Japan, it will also be necessary to make efforts
to deal with occupational rhinitis under a broader
definition, which includes occupational non-allergic
rhinitis.
Occupational Allergic Diseases
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3.2. Classification
CQ2: How is occupational allergic rhinitis classified?
(1) Type I in the Coombs & Gell Classification has
been reported, and types IV and III are possible.
(2) Antigens are not limited to the workplace; they
might exist in the general public.
(3) There are classifications of severity and disease
type, which are important for treatment.
3.3. Epidemiology
CQ3: What is the prevalence of occupational allergic
rhinitis?
Overseas, the prevalence has been reported to range
from 0.2% to 16.1% according to exposed allergens in
individual occupations. In Japan, the incidence rate of
occupational allergic rhinitis among all allergic rhini-
tis cases is reported to be 0.6-3.0%.15
3.4. Causes
CQ4: What are causative antigens for occupational al-
lergic rhinitis?
Animals, plants, chemicals, and so forth.16 [A]
CQ5: What are the criteria for certifying causative anti-
gens of occupational allergic rhinitis?
It is diagnosed through a combination of doctor’s
questions, immunological examinations, and a nasal
mucosa test.16,17 [A]
CQ6: Are causative antigens of occupational allergic
rhinitis changing?
Both type and incidence rates have been changing
due to changes of industrial form and working envi-
ronment.
CQ7: What are problems related to chemical-induced
occupational allergic rhinitis?
Because specific IgE antibodies cannot be easily de-
tected, diagnosis is difficult.16 [A]
CQ8:What are the mechanisms for the occurrence of oc-
cupational allergic rhinitis?
(1) It is a disease whose allergic immunologic mecha-
nism and process are most clearly defined, and is
only a precious human model of pure allergic disease
induced by single antigen.
(2) Although essential differences in the mechanism
have not been indicated, there are some cases of in-
tense exposure to antigens at the workplace that are
substantially different from ordinary situations.
(3) Some cases have reported a genetic predisposi-
tion in which biophylactic reaction symptoms are me-
diated by an IgE antibody.
3.5. Treatment
CQ9: What are characteristic problems for the avoid-
ance of antigens for occupational allergic rhinitis?
(1) Continuous exposure to antigens at workplaces
leads allergic rhinitis to develop asthma, which is a
severe airway disease. [C1]
(2) Continuing work might become difficult. [C1]
(3) The disease restricts the patient and brings about
issues such as a reduction in productivity. [C1]
CQ10: Are drug therapies effective for occupational al-
lergic rhinitis?
(1) They are effective.17 (C1)
(2) It is desirable to avoid asthma advancement by
continuously working in the same environment. [C1]
CQ11: Is specific immunotherapy effective for occupa-
tional allergic rhinitis?
It is effective. [C1]
CQ12: Is surgical therapy effective for occupational al-
lergic rhinitis?
It is effective. [C1]
CQ13: Is treatment of occupational allergic rhinitis dif-
ficult?
(1) Although avoiding antigens is a highly effective
treatment, losing the job or natural endowment could
occur. [C1]
(2) Continual exposure to an antigen at the workplace
might cause allergic rhinitis to advance to asthma.
[C1]
(3) It is difficult to specify a causative antigen in many
cases. [C1]
3.6. Prevention
CQ14:What is the highest priority in its prevention?
To specify an inhaled antigen and completely elimi-
nate it from the workplace. Complete avoidance of in-
haled antigens at the early stage is important, which
will be achieved by changing to alternative agents
without a sensitizing nature or completely sealing off
relevant areas.16,18 [A]
CQ15: Is it effective to reduce the concentration of ex-
posed antigen by setting up ventilation devices at the
workplace?
Although it is effective to reduce inhalation by utiliz-
ing full ventilation or local ventilators, such as push-
pull ventilation, complete avoidance is more effective.
[B]
CQ16: Is it effective to substitute materials without a
antigenicity?
If materials without a sensitizing nature or with a less
sensitizing can be used, it will be as effective as either
a reduction or complete avoidance of exposure to in-
haled antigens. [B]
CQ17: Is it effective to wear respiratory protective tools,
such as dust or gas protective masks, at the workplace?
It is effective to avoid and reduce exposure to anti-
gens by appropriately using protective tools. [B]
CQ18: Is it effective to inspect for the presence or ab-
sence of atopic diathesis before employees begin work-
ing?
This might not always be effective. [C1]
CQ19: Is education on labor hygiene effective as preven-
tive measure?
It is effective to educate about the symptoms, exacer-
bation factors, protective tools, treatments, and so
forth related to occupational allergic rhinitis. [B]
CQ20: Is it effective for industrial physicians to conduct
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Table　6　Types of occupational skin diseases
Occupational skin diseases Main causes
 1. Contact dermatitis
(1) Allergic contact dermatitis
(2) Irritant contact dermatitis
(3) Photocontact dermtitis
Metals (nickel, chrome etc.), epoxy resin, acrylic resin, rubber, agrichemicals, cutting oil, 
cleansers, plants
(1) Main acute irritant, erosive (including chemical burn) causative agents: hydrogen fl uo-
ride, cement, heating oil, hydrogen peroxide
(2) Irritant reactive causative agents: surfactants, disinfectants, cosmetics, epoxy resin
 2. Ultraviolet hazards Acute lesions (sunburn, suntan), chronic lesions (optical aging, skin cancer)
 3. Urticaria Contact urticaria: wheat
 4. Acne Oil acne, chloracne, taracne
 5. Pigmentary abnormality Absence of the pigment (hydroquinone, phenylphenol, alkyl phenol) 
Pigmentation (ultraviolet light, tar and pitch, arsenic)
 6. Radiodermatitis Acute radiodermatitis, chronic radiodermatitis
 7. Tar and pitch dermatopathy Pigmentation, acne, Bowen’s disease, squamous cell cancer
 8. Aresevic dematopathy Keratosis, cutaneous melanosis, Bowen’s disease, squamous cell cancer
 9. Heat injury Electric damage, chemical burn
10. Cold injury
11. Skin cancer Bowen’s disease, squamous cell cancer
12. Skin circulatory disorder
13. Infection/insect sting
From reference 1.
an inspection tour through workplaces once or more per
month?
Refer to CQ31 of section 2.
4. Occupational Skin Diseases
4.1. Definition and Classification
CQ1: What is the definition of occupational skin dis-
eases?
Diseases closely related to occupation are called oc-
cupational diseases and skin-related diseases at the
workplaces are called occupational skin diseases.19
CQ2: How are occupational skin diseases classified?
There are so many types of occupational skin dis-
eases (Table 6).19
CQ3:What is occupational irritant contact dermatitis?
It is defined as “non-immunological local inflamma-
tion characterized by erythema, edema, and erosion
occurring after a single or repetitive exposure to cer-
tain skin sites.”
CQ4:What is occupational allergic contact dermatitis?
The disease occurs in certain individuals and sensiti-
zation reaction involving an immunological mecha-
nism is required.
CQ5: What is occupational urticaria? What is occupa-
tional contact urticaria?
Urticaria in which there is an apparent causal associa-
tion with occupation is called occupational urticaria in
a broad sense. Contact urticaria in which there is an
apparent causal association with occupation is called
occupational contact urticaria.
CQ6: What is occupational protein contact dermatitis
(PCD)?
The disease refers to repeated recurrent allergic con-
tact dermatitis occurring at contact sites in which pro-
tein becomes a causative allergen. The pathogenesis
of this dermatitis is assumed to be different from that
of type IV allergic contact dermatitis in which hapten,
a chemical, becomes a causative allergen.20-22
4.2. Epidemiology
CQ7: What is the prevalence of occupational skin dis-
eases?
There are more than 57,000 types of chemicals used
in the industrial sector in Japan. More than 500 kinds
are introduced into workplace annually. Thus, it is dif-
ficult to evaluate the prevalence.
CQ8: What is the prevalence of occupational contact
dermatitis?
It is very high.
CQ9: What is the prevalence of occupational urticaria
and occupational contact urticaria?
The prevalence of these diseases, other than latex al-
lergy, has not been reported accurately in Japan.
4.3. Causative Agents
CQ10:What are the causative agents of occupational ir-
ritant contact dermatitis?
Chemical burn, which is an extreme type of acute irri-
tant contact dermatitis, is caused by acidalkali, hy-
drogen fluoride, cement, heating oil, and so forth.19
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Table　7　Highly frequent allergens causing occupational contact dermatitis
Causative agents Symptoms and summary
Metals (nickel, cobalt, chrome) Contact dermatitis syndrome expanding beyond the contact site or systemic metal allergy 
may occur. In many cases, it occurs through contact with agents containing metals (leather, 
coating materials, etc.).
Resin, epoxy resin, acryl resin Dermatitis occurs not only at the hands, but also at the face. Airborne micro-powder induces 
symptoms. Besides factory workers, it can occur in dental hygienists.
Rubber (MBT, TMTD) At workplaces, rubber gloves and boots might cause frequent problems.
Agrichemicals (herbicides, 
antibacterial agents)
Erythema, lichen, or cracks might occur at the face/neck or hands if exposed. Repetitive 
contact induces a chronic condition in many cases. Photocontact dermatitis can also occur.
Cutting oil, machine oil Acne may occur. Various substances are contained in cutting oil and it is difficult to specify
the cause.
Plants Refer to Table 8.
From reference 1.
Table　8　Plants causing contact dermatitis
Disease type Representative plants Main causative substances Symptoms and summary
Irritant contact 
dermatitis 
(mechanical irritation)
Rose, Aralia elata, cactus
Aloe arborescens, kiwi fruit, 
pineapple, Araceae
Calcium oxalate 
(needle-like crystal)
Needle-like crystal becomes me-
chanical irritant. Dermatitis caused 
by aloe is reported to be an irritant 
infl ammatory reaction similar to an
allergic reaction.
Irritant contact 
dermatitis 
(chemical irritation)
Nettle Histamine, acetylcholine, 
serotonin
Pedicles and leaves of urticaceae 
have many nettling hairs. Touching 
them causes urticaria. Dried types 
change to non-irritant anemonin.
Ranunculus glaber, 
Clematis ternifl ora
Protoanemonin
Allergic contact 
dermatitis
Anacardiaceae 
(poison oak, poison ivy, 
Toxicodendron trichocarpum, 
Toxicodendron sylvestre, 
Japanese wax tree
Urushiol Anacardiaceae grow in the wild. If
one makes contact, 2-3 days later
strong itchiness occurs, edematous 
erythema or water blisters occur 
and arrange linearly.
Ginkgo 
(outer seed coat), 
maidenhair tree
Ginkgolic acid, bilobol 
(easily crossed with 
Urushiol)
Outer seed coat of ginkgo has an 
antigenic substance, and the leaves
also contain trace amounts.
Primula Primine Primula without primine has recently 
been commercialized.
Compositae 
(mum, Margaret, sunfl ower, 
dahlia, Artemisia, lettuce, etc.)
Sesquiterpene lactones 
(alantolactone, Arteglasin A)
Compositae has several variations.
Araliaceae; (Dendropanx trifi -
dus trees, fatsia, rhombea)
Falcarinol
Liliaceae (tulip) Tulipalin A The bulb contains the antigenic 
substance.
Labiatae (beefsteak plant) Perillaldehyde, perillalchol The oil component contains the an-
tigenic substance.
Photocontact 
dermatitis
Umbelliferae (celery, parsley), 
Rutaceae (lime, lemon), 
Moraceae
Furocoumarin is the cause 
substance. It is the psoralen-
allied substance.
After touching the fruit juice or leaf
juice, if sunlight reaches the site(s), 
dermatitis occurs.
From reference 1.
CQ11: What are the causative agents of occupational
allergic contact dermatitis?
These are presented in Table 7-9.
CQ12: What are the causative allergens for occupa-
tional urticaria (occupational contact urticaria)?
Main causative proteins include foods, plants, ani-
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Table　9　Causes of contact dermatitis by occupations
Job type Contact dermatitis Causes
Agriculture
Acute irritant dermatitis Agrichemicals (organic phosphates, herbicides), farm products
Chronic irritant dermatitis/
Allergic contact dermatitis
Agrichemicals, fertilizer, farm products, grass pollen, surfactant
Industrial
Acute irritant dermatitis Rust-preventive agents, heating oil, cutting oil, tar, phenol
Chronic irritant dermatitis/
Allergic contact dermatitis
Coating agents, metals (nickel, cobalt, chrome), surfactant, epoxy resin, rub-
ber agents, cutting oil
Beauticians
Irritant dermatitis Hair, surfactant (Cocamidopropyl betaine: CAPB), permanent wave solution 
(Ammonium thioglycolate [ATG])
Allergic contact dermatitis Surfactant (Paraphenylenediamine [PPD]), permanent wave solution, fragranc-
es, bleach agents (ammonium persulfate, scissors [metals]), rubber gloves
(vulcanizing accelerator, latex), disinfecting antiseptic agent (caisson CG)
Medical workers
Irritant dermatitis Hand cleansers, disinfectants (povidone iodine, benzalkonium chloride,
chlorhexidine gluconate)
Allergic contact dermatitis Disinfectants, materials for dental case (resin), rubber gloves (Vulcanisation
accelerators, latex; contact urticaria, latex)
Clerical workers Allergic contact dermatitis Deskmat (2, 3, 5, 6-tetrachloro-4-metylsulfonyl pyridine [TCMSP])
Table　10　Causative allergens for contact urticaria other than latex that have been reported in Japan
Type Causative allergens
Food related Crustacea, fi sh and shellfi sh, fruits and vegetables (red-leaved chicory, chicory, avocado, garlic,
cotton seed), rice, wheat, eggs, cow’s milk, buckwheat, gelatin
Animal related Chironomid larva (feeds for breeding), silk, house dust mites, skin fragments
Antibacterial drugs Cefotiam, cefoperazone, streptomycin, piperacillin, pentoxifylline
Chemicals Henna (hair dye), para-aminophenol, para-phenylendiamine, para-toluenediamine, meta-amino-
phenol, orthoaminophenol (hair dye), Ammonium persulphate (hair bleaching agent), methylpara-
ben (cosmetics, shampoo, toothpaste, etc.), polyoxyethylene alkyl ether (cleanser), polyethylene 
glycol (cleanser), benzalkonium chloride, chlorhexidine gluconate, formalin
Others (enzymes and 
protein hydrolysates, etc.)
Papain (proteolytic enzyme, cleansers and face-washes), hydrolyzed collagen (cosmetics), gela-
tin (hair care product, Glupearl (hydrolyzed wheat, face-washes, hair care products, cosmetics)
From reference 1.
mals, wheat, crops, natural rubber products, and so
forth. The causes of non-allergic urticarial include
chemicals such as fragrances or preservatives (Table
10).
CQ13: Can latex allergy induced by rubber glove become
a cause of food allergy onset?
Some patients with latex allergies have an immediate
allergic reaction to certain kinds of plant foods (latex
fruit syndrome).23
CQ14: Are there food allergies induced by soaps, sham-
poos, and pack agents containing food components such
as hydrolysate?
There have been wheat allergy cases in which pa-
tients using soaps containing hydrolyzed wheat pow-
der were percutaneous-mucosally sensitized by hy-
drolyzed wheat powder. By March 26, 2013, there
had been 1,830 definitive cases in Japan (1,750 female
cases (95.8%) and 76 male cases (4.2%)) caused by
soaps. Approximately half of these cases were life-
threatening cases, such as anaphylaxis (Japanese So-
ciety of Allergology: “Special Committee for Safety of
Protein Hydrolysates in Cosmetics” Head: Kayoko
Matsunaga).
CQ15:What is cochineal allergy?
It is an acute immediate allergy reaction induced by
intake of drinksconfectionery and use of cosmetics
containing a cochineal pigment as an additive. The al-
lergy is assumed to increase in the future.24
CQ16: Which workplaces have high incidences of con-
tact urticaria?
The food processing industry, bread makers, chefs,
agricultural workers, beauticianshairdressers, and
medical-care workers who handle protein allergens.
Non-allergic contact dermatitis has been occurring in
food processing industry as well as among beauti-
cianshairdressers and medical care workers who
handle food preservatives, fragrances, and disinfec-
tants.
CQ17: What is occupation in which occupational con-
tact urticaria associated with food allergens might be
more likely to occur? What are causative allergens?
There have been reports that food-related proteins
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Fig.　2　Procedures of diagnosis. From reference 1.
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Table　11　Evaluation criteria
Criteria in Japan 29 ICDRG criteria
Positive reaction: 
++ or more Reaction
Positive reaction: 
+ or more Reaction
- No reaction - No reaction
± Mild erythema +? Only erythema
+ Erythema + Erythema + infi ltration, papula
++ Erythema + edema, papula ++ Erythema + infi ltration + papula + small 
water blister
+++ Erythema + edema + papula + small 
water blister
+++ Large water blister
++++ Large water blister IR Irritant reaction
NT Not conducted
contained in cosmetics can become causative aller-
gens for hairdressers, beauticians, as well as chefs. In
the future, such allergies could increase.25,26
4.4. Diagnosis
CQ18: Is the patch test useful for diagnosis?
It is required to evaluate for the presence or absence
of irritability in agents or identify causative agents for
allergic contact dermatitis.27
CQ19:What is the procedure for the patch test? (Fig. 2)
Allergens are presumed from occupation or contents
of the work, and a photopatch test or patch test is
then conducted.
CQ20:What is the effect of the patch test?
Clarification of the causative contact allergen will lead
to radical cure of intractablerecurrent allergic con-
tact dermatitis.
CQ21:What types of patch test units are recommended?
The International Contact Dermatitis Research Group
(ICDRG) recommends Finn ChamberⓇ on Scanpor
tape (Alpharma AS, Oslo, Norway).
CQ22:What are allergens for patch tests?
There are 25 kinds of Japanese standard allergens.28
CQ23: What are precautions for conducting the patch
test?
They include preservation method of allergens, appli-
cation sites, pregnant women, and a combination with
oral medicines.
CQ24: What are the procedures for the patch test (sim-
ple closure test)?
Preparation of unit, cloth-application method, removal
of the unit, and evaluation time are prescribed.
Dobashi K et al.
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Fig.　3　Algorism of treatment. From reference 1.
†Oral steroid is limited to severe cases.  After elimination of the cause,  20-30 mg/day for about one week.
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CQ25: Are there other patch test methods?
The open test, photopatch test, and repeated open ap-
plication test (ROAT).
CQ26: How is the patch test evaluated?
The criteria are the Japanese criteria28,29 and those
from the International Contact Dermatitis Research
Group (ICDRG) (Table 11).
CQ27: What is required for diagnosis of occupational
urticaria (occupational contact urticarial)?
The prick test is listed as a highly sensitive and spe-
cific test method that is accessible at many facilities.30
CQ28: What are the procedures for the prick test? What
is the nature of the practice and what are the precau-
tions?
We must always have adrenaline preparations ready
for emergency, and must exercise caution against
pseudo-negative and pseudo-positive results.31
CQ29: What is the “as is prick test” using crude anti-
gens?
It means a test using fruits or vegetables as subjects.
It is appropriate to use the “prick by prick test.”
CQ30: How are allergens used in the prick test ad-
justed?
Because adjustment methods are different between
agents, in cases of fresh vegetables and fruits, using
those themselves is useful. As for latex, extracted
fluid is prepared.
CQ31: How is the prick test evaluated?
The diameter of the urticarial lesion (the mean level
of the vertical diameter at the middle point with the
maximum length diameter in mm) is measured after
15 minutes. The evaluation is conducted by compar-
ing with the control.
CQ32: Is the measurement of allergen-specific IgE anti-
body titer by molecular allergology (MA) useful for the
diagnosis of occupational urticaria (occupational con-
tact urticaria)?
It is useful for diagnosis that the allergen-specific IgE
test using purified antigen is conducted to under-
stand the sensitized condition. [A]
CQ33: What sites are likely to have occupational con-
tact urticaria?
As with occupational contact dermatitis, it appears
that the hands are most likely, followed by contact
hand joints, upper arm, and face.
4.5. Treatment and Management
CQ34: How do they deal with the onset of occupational
contact dermatitis?
In cases in which the causal association between the
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cause and the work (work-originated) is apparent, the
event is notified to industrial physicians and person-
nel in charge of health and safety in the place of busi-
ness to which the patient belongs.
CQ35: How do they deal with the onset of occupational
contact urticaria?
It is most important to identify a causative allergen
and then to avoideliminate it. Because it is likely to
be comorbid with atopic dermatitis or irritant derma-
titis, which is an etiology for skin barrier impairment,
alleviating these symptoms is necessary.32
CQ36: What are drug therapies for occupational con-
tact dermatitis?28 (Fig. 3)
(1) Oral steroids and topical steroids are effective.
[A]
(2) Anti-histamine drugs are effective. [B]
(3) Immunosuppressors are effective. [C1]
(4) For chronic hand eczema, ultraviolet is effective.
(4)-1 PUVA [A]
(4)-2 NB-UVB [B]
(5) Barrier-cream gloves are effective for prevention.
(5)-1 Irritant dermatitis [A]
(5)-2 Contact dermatitis [B or C1]
CQ37: What are basic treatment procedures for occupa-
tional contact urticaria?
Identifying and avoiding causative allergens.28 [B]
4.6. Prevention
CQ38: How is occupational contact dermatitis pre-
vented?
Avoiding contact with relevant chemicals and reduc-
ing harmful work as much as possible.
CQ39: How can occupational contact urticaria be pre-
vented?
(1) Use of rubber gloves, vinyl gloves, mask, protec-
tive cloth, and so forth, are recommended for avoid-
ing causative allergens. [C1]
(2) Because antecedent pathologies such as atopic
dermatitis or irritant contact dermatitis are often
comorbid, use of moisturizing agents and preventive
creams can be preventative against the worsening of
symptoms. [C2]
CQ40:What is the highest priority for prevention?
Complete elimination of causative allergens and irri-
tants from the workplace.33 [A]
CQ41: Is it effective to substitute materials with a low
antigenicity or without an antigenicity?
Gloves containing latex can be replaced with those
with lower or no antigenicity.34 [B]
CQ42: Is it effective to wear gas or dust protective masks
and respiratory protective tools at the workplace?
For prevention of dermatitis, protection of the skin is
the highest priority.
CQ43: Is it effective to wear gloves at the workplace for
prevention?
If used appropriately, they are effective. However,
caution is required.35 [B]
CQ44: Is it effective to apply cream?
Although applying barrier (protective) cream before
work is not recommended, applying moisturizing
agents after work are effective.
CQ45: Is it effective to inspect for the presence or ab-
sence of atopic diathesis before employees begin work-
ing?
This is not prescribed as a duty.
CQ46: Is education on labor hygiene effective as preven-
tive measure?
Specialized education regarding skin diseases and
skin care is effective for preventing occupational con-
tact dermatitis.33 [A]
CQ47: Is it effective for industrial physicians to conduct
an inspection tour through workplaces once or more per
month?
Refer to CQ30 from section 1.
5. Hypersensitive Pneumonitis
5.1. Identification and Classification
CQ1: What is the definition of occupational hypersensi-
tive pneumonitis?
Repetitive inhalation of fungus and bacteria floating
within the work environment, excretory substances
and body constituent of animals, and other organic
inorganic chemicals induced to establish per-airway
sensitization, causing pulmonary alveolitis. [A]
CQ2: What is the classification of occupational hyper-
sensitive pneumonitis?
Those are classified into acute type, sub-acute type,
and chronic type according to manner of onset.
5.2. Epidemiology
CQ3:What is the prevalence of occupational hypersensi-
tive pneumonitis?
Because it is influenced by the type of antigen and na-
ture of exposure, it is difficult to conduct definitive
epidemiologic evaluations at present. It is reported in
Japan that the incidence of farmer’s lung is 5.8% and
bird breeder’s disease among pigeon breeders is
10.4%.36
CQ4: What is the mortality of occupational hypersensi-
tive pneumonitis?
Generally, the mortality is believed to be low. The
mortality increases in cases of chronic types with pul-
monary fibrosis.
CQ5: What are the regional and seasonal characteris-
tics in occupational hypersensitive pneumonitis?
Pneumonitis occurs at a high rate in regions and sea-
sons in which the probability of exposure to causative
antigens is high.
5.3. Causative Antigens
CQ6:What are causative antigens?
Plant powder dust, body constituent and excretory
substances of animals, insects, fungi, bacteria, drugs,
organic chemicals, and so on. [A]
CQ7: What are the criteria to certify causative antigens
of occupational hypersensitive pneumonitis?
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Table　12　Inhaled agent inducing occupational hypersensitive pneumonitis
Inhaled agent inducing occupational 
hypersensitive pneumonitis Occupations (disease name)
Evidence level
Overseas/Japan
1. Plant antigens
Wheat Confectionery making (wheat fl our lung) (2) (3)
2. Fungi/yeast
Aspergillus niger Dairy farming (farmer lung) (3)
Aspergillus oryzae Miso and soy sauce makers (3)
Shiitake mushroom spores Cultivation of shiitake mushrooms (2)
Nameko mushroom spores Cultivation of nameko mushrooms (2)
Trichosporon cutaneum Cultivation of nameko mushrooms (3)
Shimeji mushroom spores Cultivation of shimeji mushrooms (1)
King trumpet mushroom spores Cultivation of king trumpet mushrooms (2)
Polypore mushroom spores Cultivation of polypore mushrooms (2)
Penicillium citrinum Cultivation of enoki mushrooms (2)
Fungi mixed and growing Saccharopolyspora recti-
virgula (Micropolyspora faeni) 
Lungs of persons cultivating mushrooms (3)
Fungi attaching to rush Tatami mat makers (3)
Contaminated water Workers in humid working environments 
(humidifi er lung, ventilator lung)
(2)
Aspergillus fumigatus Orchid planters (3)
Aspergillus fumigatus Vegetables planters in plastic greenhouse, 
vegetable planters (compost lung)
(2) (3)
Aspergillus spp. Penicillium sp. Paecilomyces sp. Mandarin orange planters (2)
Penicilliun spp. Wooden pulp workers
Greenhouse rose cultivators (2)
3. Bacteria, acid-fast bacillus, actinomycete
Saccharopolyspora rectivirgula 
(Micropolyspora faeni)  (Contaminated water)
Workers at humid working environments 
(humidifi er lung, ventilator lung) (1) (1)
4. Other organics
Shellfi sh powder dust Nuclear processing traders for pearl aquafarming (3)
Marine univalve shell Mollusk shell HP (2) (2)
Pearl oyster powder dust Shellworkers (2)
Freshwater shellfi sh powder dust Pearl nuclear processing traders (3)
Makomozumi 
(Makomozumi makers, Ustilago esculenta spores)
Traditional craftwork workers lung (3)
5. Chemicals (metals, drugs, inorganics, etc.)
Isocyanate (toluene diisocyanate [TDI], methylene 
diisocyanate [MDI], hexamethylene diisocyanate 
[HDI], etc.)
Paint applicator lung, automobile mechanics, 
casting metal workers, piano mechanics 
(use of polyurethane)
(1) (2)
Cobalt Hard metal disease (2) (2)
6. Unconfi rmed (candidate)
Powder dust occurring at use of mobile bed disinfec-
tant device Assistant nurses (3)
Evidence levels of causative antigens are defined ac-
cording to Table 3 and antigens are listed in Table 12.
Only causative antigens reported in Japan are listed.
CQ8: What are the causative antigens with high inci-
dence in occupational hypersensitive pneumonitis?
Farmer’s lung has been decreasing. Reports on vari-
ous causes have been increasing because of the rec-
ognition of diseases and consequent increase in diag-
nostic rates (Table 13, 14).
CQ9: What are causative antigens that have been in-
creasing recently in occupational hypersensitive pneu-
monitis?
Low molecular weight chemicals.
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Table　13　National epidemiologic surveys on acute hyper-
sensitive pneumonitis
Disease name
1980-1989 1990-1999
Number of 
patients (%)
Number of 
patients (%)
Summer-type hypersensi-
tive pneumonitis
621  (74.4) 624  (69.8)
Farmer’s lung  68   (8.1)  39   (4.4)
Ventilator lung  36   (4.3)  53   (5.9)
Bird breeder’s lung  34   (4.1)  36   (4.0)
Other hypersensitive pneu-
monitis
 19   (2.3)  68   (7.6)
Unknown cause  57   (6.8)  74   (8.3)
Total 835 (100.0) 894 (100.0)
Adapted from reference 37.
Table　14　National epidemiologic surveys of chronic hypersensitive pneumonitis
1989-1998 2001-2010
Disease name Number of patients (%) Disease name
Number of 
patients (%)
Summer-type hypersensitive 
pneumonitis
10  (27.8) Summer-type hypersensitive pneumonitis  33 (20)
Bird breeder’s lung  7  (19.4) Hypersensitive pneumonitis associated with birds  86  (52.1)
Isocyanate induced  5  (13.3) Isocyanate induced   1   (0.6)
Hypersensitive pneumonitis asso-
ciated with houses
 5  (13.9) Hypersensitive pneumonitis associated with 
houses
 26  (15.8)
Farmer’s lung  4  (11.1) Humidifi er lung   2   (1.2)
Other hypersensitive pneumonitis  5  (13.9)
Unknown cause Unknown cause  17  (10.3)
Total 36 (100.0) Total 165 (100.0)
Adapted from reference 38.
5.4. Risk Factors for Onset
CQ10: What are environmental factors that might pre-
dispose one to be at risk for occupational hypersensitive
pneumonitis?
Antigen concentration, exposure period, exposure
frequency, non-smoking, and so forth.39
CQ11: What are genetic factors that might be a risk fac-
tor for occupational hypersensitive pneumonitis?
Specific genetic factors have not been sufficiently elu-
cidated.
5.5. Diagnosis
CQ12:What are diagnostic criteria for occupational hy-
persensitive pneumonitis?
There are no independent diagnostic criteria for oc-
cupational hypersensitive pneumonitis. The diagnosis
is made based on the “Guideline for Diagnosis and
Treatment of Hypersensitive Pneumonitis”40 pre-
pared in 1990 by the Investigation and Research
Group of Specific Diseases and Diffuse Diseases of
Ministry of Health, Labour and Welfare, Japan. [A]
CQ13: What are differential diagnoses for which cau-
tion must be exercised in occupational hypersensitive
pneumonitis?
Other interstitial lung diseases such as idiopathic in-
terstitial pneumonitis and occupational asthmas. [A]
CQ14: What is the most important point in diagnosing
occupational hypersensitive pneumonitis?
Physician questions are the most important. In par-
ticular, a detailed occupational history is required.
[A]
CQ15: What examination methods are used for occupa-
tional hypersensitive pneumonitis?41
(1) General blood examinations, imaging (X-ray and
CT), examination of respiratory function, bronchoal-
veolar lavage (BAL), and tracheobronchial lung bi-
opsy (TBLB). [A]
(2) To identify causative antigens, measurement of
antigen-specific antibody titer, lymphocyte prolifera-
tion test by addition of antigen, precipitation antibody
test, challenge tests such as the antigen inhalation
challenge test, and the environmental challenge test
are listed. [A]
CQ16: Is tissue diagnosis required for definitive diagno-
sis of occupational hypersensitive pneumonitis?
Tissue diagnosis is not always required. [C1]
CQ17: Is the antigen inhalation challenge test required
for definitive diagnosis of occupational hypersensitive
pneumonitis?
It is useful for definitive diagnosis to identify anti-
gens. Because it is accompanied by the risk of exac-
erbation of hypersensitive pneumonitis, it is not es-
sential. [C1]
CQ18: Are immunological examinations useful for de-
finitive diagnosis of occupational hypersensitive pneu-
monitis?
They are useful for indirect diagnosis.42 [C1]
5.6. Treatment, Management, and Prognosis
CQ19: What are treatments for occupational hypersen-
sitive pneumonitis?
The avoidance of antigens. Prednisolone as a sympto-
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Table　15　Clinical criteria for diagnosing anaphylaxis
If one or more of the following three criteria are fulfi lled, the probability of anaphylaxis is high.
1. In addition of skin symptoms (systemic urticaria, itch, or fl ush) and/or mucosal symptoms (swelling of the lips, tongue, or uvu-
la) occurring suddenly several minutes or hours later, the following complications: 
Respiratory symptoms (dyspnea, wheezing, hypoxemia, etc.)
Hypotension, peripheral cardiovascular failure (faintness, impaired consciousness, or incontinence)
2. Two or more following symptoms occurring suddenly several minutes or several hours after exposure to allergens or others 
(non-IgE allergens or non-allergic mast cell irritant factors):
Skin, mucosal symptoms (systemic urticarial, itch or fl ush, and swelling of the lips, tongue, and uvula)
Respiratory symptoms (dyspnea, wheezing, hypoxemia, etc)
Hypotension, peripheral cardiovascular failure (faintness, impaired consciousness, incontinence)
Persistent gastrointestinal symptoms (Spastic abdominal pain, vomiting)
3. Hypotension occurring several minutes or several hours after an episode appeared to be exposed to known allergens (bee 
puncture or injection in specifi c immunotherapy)
In cases of infants/children, taking age into consideration, systolic arterial pressure decreases abnormally† or to less
than 70% of normal pressure.
In adult cases, systolic pressure decreases to less than 90 mmHg or less than 70% of normal pressure.
†Abnormal hypotension is less than 70 mmHg at one month to one year after birth, less than 70 mmHg + 2 × age at ages 1-10, less than 
90 mmHg at ages 11-17. Normal heart rate is 80-140 times/min at ages 1-2, 80-120/min at age 3, and 70-115/min at age 4 or older. In in-
fants, dyspnea rather than hypotension or shock often occurs, and tachycardia is a useful sign as a precursor to the shock.
Adapted from reference 1.
matic therapy is used for intermediate and severe
cases of acute hypersensitive pneumonitis or cases of
advancing chronic hypersensitive pneumonitis.43,44
[A]
CQ20: Is it possible for patients with occupational hy-
persensitive pneumonitis to continue working only
through drug treatment?
Avoidance of antigens is inevitably necessary and pa-
thologic conditions after avoiding the antigen by leav-
ing the job could progress.43 [D]
CQ21: What is the prognosis for occupational hypersen-
sitive pneumonitis?
Individuals with mild cases who avoid the antigen
have a favorable prognosis. The prognosis is poor,
however, in cases in which the antigen cannot be
avoided or in chronic fibrotic cases that show poor re-
sponse to treatment.45
5.7. Prevention
CQ22: What is the highest priority in management of
the working environment?
Complete elimination of causative antigens.46 [A]
CQ23: Is it effective to reduce exposure to antigens by
setting up ventilation devices at the workplace?
It is effective. [C1]
CQ24: Is it effective to wear dust or gas protective masks
at the workplace as a preventative measure?
It is effective.46 [B]
CQ25: Is it effective to inspect for the presence or ab-
sence of atopy before employees begin working?
This might not be effective. [C2]
CQ26: Is education on labor hygiene effective as preven-
tive measure?
It is effective in educating workers regarding symp-
toms of occupational hypersensitive pneumonitis, the
avoidance of antigens, and the correct uses of protec-
tive tools. [C1]
CQ27: Is it effective for industrial physicians to conduct
an inspection tour through workplaces once or more per
month?
Refer to CQ30 from section 1.
6. Occupational Anaphylaxis (Shock)
6.1. Definition
CQ1: What is the definition of occupational anaphy-
laxis?
It is an anaphylaxis that occurs or worsens because of
exposure to a causative antigen at the workplace. [B]
6.2. Symptoms and Diagnosis of Anaphylaxis
CQ2:What are diagnostic criteria for anaphylaxis?
Although diagnostic criteria are nonexistent, clinical
evaluation criteria based on the content of physician’s
questions and characteristic symptoms exist (Table
15).47,48 [A]
6.3. Epidemiology of Anaphylaxis
CQ3: What are the incidence and prevalence rates of
anaphylaxis?
The incidence is estimated to be 0.05-2.0% and tends
to be increasing worldwide.49 [C1]
CQ4:What are main causes of anaphylaxis?
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Table　16　Treatment of anaphylaxis at the acute stage
Items that must be executed fi rst:
 1) Bring the written emergency protocol for recognizing and treating anaphylaxis and acquire profi ciency in executing it.
 2) Eliminate known inducing factors (for example, if a contrast medium or drug is suspected, it must be discontinued).
 3) Conduct basic evaluations for fi rst aid (vascular circulation, airway, respiration, consciousness condition, skin signs, body
weight, etc.).
Treatments that must be conducted promptly:
 4) Call for help (for inpatients, the resuscitation team; for outpatients, the emergency and rescue team).
 5) When anaphylaxis is diagnosed, intramuscularly administer 0.1% adrenaline (0.01 mg/kg, the maximum dose is 0.5 mg in 
adults and 0.3 mg in children) at the anterior external side in the center of the femoral region.
Record the time of the injection and, when necessary, repeat the injection every 5-15 minutes. Usually, one or two injec-
tions is effective.
 6) Lay the patient down in supine position or, in case of dyspnea and/or vomiting, change the body position appropriately in ac-
cordance with the patient’s condition. Uphold the lower limbs. Avoid standing up and coming to a sitting position too quickly.
Treatment should be conducted as needed:
 7) Administer oxygen at a high-fl ow volume (6-8 L/min.) through the nasotracheal airway using a facemask.
 8) Place a vascular needle or catheter (inner diameter 14-16 G), and administer 1-2 L of normal saline solution by drip infu-
sion intravenously.
(In adults, for fi rst 5-10 minutes, 5-10 mL/kg; in children, 10 mL/kg.)
 9) If needed, perform cardiopulmonary resuscitation by chest compression.
Continue to evaluate the situation.
10) Regularly evaluate blood pressure, heart rate, respiratory condition, and oxygenation. If possible, monitor using a respira-
tion/heart rate device.
From reference 1.
Table　17　Diseases related to occupations and causative agents
Bronchial asthma, 
rhinitis
Protease, wood dust, animal hair dust, fl uorine, vinyl chloride, synthetized resins such as acrylic resin
Wood dust: red cedar, lauan, Japanese clethra, mulberry tree
Cilia dust: sheep, cat, goat, horse, pig, scurf, mite, fungi, etc.
Other: sea squirt attaching to oyster shell, cocooning frame, drugs such as antibiotic, aspirin, sulfon-
amide, etc.
Occupations: lumber and wood processing, hair pencil maker, veterinarian, farmer, handling experimental
animals, drug manufacturer, medical work, drug preparation at pharmacy
Skin disease/
dermatitis
(In addition to agents associated with bronchial asthma and rhinitis), soot (black printing ink, artifi cial 
coal), mineral oil (lubricant oil, electric insulator), Japanese lacquer, tar, cement, amine resin hardener 
(adhesive, condenser, coating compounds), glass fi ber, rubber additive
Adapted from reference 55.
The number of annual deaths in Japan is approxi-
mately 60. Two major causes are pharmaceutical
drugs (increasing) and bee punctures (decreasing).
[C1]
6.4. Treatment of Anaphylaxis at the Acute Stage
CQ5:What are the treatments at the acute stage?
Those are shown in Table 16.50 [A]
6.5. Causative Agents of Anaphylaxis
CQ6:What are causes of occupational anaphylaxis?
Foods (in children), drugs and insects (bees, etc.) (in
adults) are reported as causes in many cases. Causes
strongly associated with occupational exposure are
bees and latex.47,50 [B]
6.6. Anaphylaxis by Bee Puncture
CQ7: In what occupations is anaphylaxis caused by bee
puncture most likely to occur?
The forest industry, apiculture, agriculture, landscap-
ing, and so forth are listed.51 [A]
CQ8: How is bee allergy diagnosed?
Although screening is conducted with a bee toxin-
specific IgE antibody, the specificity is insufficient
and medical history is most important for diagnosis.
[B]
CQ9: What is the highest priority for prevention of ana-
phylaxis induced by bees?
To avoid bee punctures by environmental arrange-
ment. [A]
CQ10: Is it effective to inspect for the presence or ab-
sence of atopic diathesis before employees begin work-
ing?
The more medical history of allergies one has, the
higher the incidence of systemic symptoms by bee
punctures, and the higher the risk of anaphylaxis.
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[C1]
CQ11: Is it effective to carry an adrenaline self-injection
kit (EpiPenⓇ) to treat anaphylaxis by bees?
It is effective.52 [A]
CQ12: Is antigen-specific immune-therapy for bee aller-
gies useful?
Although its use is desirable due to its high effective-
ness, the therapy is not covered by insurance in Ja-
pan.53 [B]
6.7. Anaphylaxis by Latex
CQ13: What occupations are susceptible to latex aller-
gies?
Medical workers and latex makers. [A]
CQ14: Is specific IgE antibody test useful for diagnosis
of latex allergies?
Although it is important as a screening examination,
its sensitivity is not 100%. [B]
CQ15: Is the prick test useful for diagnosis of latex al-
lergy?
The test is conducted for the specific IgE antibodies
negative cases in which latex allergy is suspected.49
[B]
CQ16: What are preventive measures against anaphy-
laxis by latex?
Complete elimination of agents containing latex must
be implemented in all medical practices for individu-
als with a medical history of latex allergy. [B]
7. Legal Aspects
CQ1:Who is responsible?
For occupational diseases, it is prescribed that, ex-
cept for the case of gross negligence in employees,
employers are responsible. The employer is responsi-
ble for indemnifying the employees for cure, cessa-
tion of work, disturbances, bereaved family, and so
forth.54
CQ2: Is it covered by workman’s compensation?
Certain causes (exposure conditions) and symptoms
have been prescribed administratively as subjects for
cure, cessation of work, disturbances, compensation
for bereaved families (accident compensation by em-
ployers based on the Labor Standard Act) and work-
ers’ accident compensation (payment according to
Workmen’s Accident Compensation Insurance Act).
Occupational allergic diseases such as relevant asth-
mas, skin diseases, and rhinitis are regarded as
occupation-related diseases (Table 17).55
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